Medco, Amgen Weigh in On Biosimilars at FDA Meeting


Published On: November 3rd, 2010

It’s not yet clear whether generic versions of large-molecule biologic drugs will have to undergo separate trials.

More: 
Medco, Amgen Weigh in On Biosimilars at FDA Meeting



Loading...


Comments are closed.